Skip directly to content

How Common Is ACS After Transcatheter Aortic-Valve Replacement?

Miércoles, Septiembre 2, 2020

Acute coronary syndrome is infrequent, presents most often as non-STEMI, but is associated with high early mortality.

Although as many as 50% of patients who undergo transcatheter aortic-valve replacement (TAVR) have known coronary artery disease, the incidence of acute coronary syndrome (ACS) after TAVR is unknown.

 

 


NEJM Journal Watch summary, reutilizado con permiso del Grupo NEJM.

 

Código de aprobación: PP-CVP-CHL-0005